Large Scale Characterization of the LC13 TCR and HLA-B8 Structural Landscape in Reaction to 172 Altered Peptide Ligands: A Molecular Dynamics Simulation Study

PLoS Computational Biology

Volumn 10, Issue 8, 2014, Pages

  Knapp, Bernhard ^a   Dunbar, James ^a   Deane, Charlotte M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; MOLECULAR DYNAMICS; REACTION KINETICS; STRUCTURAL DYNAMICS; T-CELLS; VIRUSES;

ADAPTIVE IMMUNE SYSTEMS; DYNAMICS SIMULATION; IMMUNOGENICITY; LARGE-SCALES; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE LIGAND; SCALE CHARACTERIZATION; SIMULATION STUDIES; STRUCTURAL LANDSCAPES; T CELLS RECEPTORS;

PEPTIDES;

ALTERED PEPTIDE LIGAND; HLA B8 ANTIGEN; PEPTIDE; PEPTIDE DERIVATIVE; PHENYLALANYLLEUCYLARGINYLGLYCYLARGINYLALANYLTYROSYLGLYCYLLEUCINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPARATIVE STUDY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HYDROGEN BOND; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS; BIOLOGY; CHEMISTRY; HUMAN; METABOLISM;

COMPUTATIONAL BIOLOGY; HLA-B8 ANTIGEN; HUMANS; MOLECULAR DYNAMICS SIMULATION; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL;

EID: 84915787472     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003748     Document Type: Article

References (72)

1. Janeway CA, Travers P, Walport M, Shlomchik MJ (2005) Immuno Biology. New York: Garland Science.
2. Lautscham G, Rickinson A, Blake N, (2003) TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. Microbes Infect 5: 291–299.
3. Schubert B, Lund O, Nielsen M, (2013) Evaluation of peptide selection approaches for epitope-based vaccine design. Tissue Antigens 82: 243–251.
4. Stranzl T, Larsen MV, Lundegaard C, Nielsen M, (2010) NetCTLpan: pan-specific MHC class I pathway epitope predictions. Immunogenetics 62: 357–368.
5. Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, et al. (2007) NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2: e796.
6. Karosiene E, Rasmussen M, Blicher T, Lund O, Buus S, et al. (2013) NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics 65: 711–724.
7. Schwaiger J, Aberle JH, Stiasny K, Knapp B, Schreiner W, et al. (2014) Specificities of Human CD4+ T cell Responses to an Inactivated Flavivirus Vaccine and Infection: Correlation with Structure and Epitope Prediction. Journal of Virology E-pub ahead of print. doi:10.1128/JVI.00196-14
8. Bryson CJ, Jones TD, Baker MP, (2010) Prediction of immunogenicity of therapeutic proteins: validity of computational tools. BioDrugs 24: 1–8.
9. Tung CW, Ziehm M, Kamper A, Kohlbacher O, Ho SY, (2011) POPISK: T-cell reactivity prediction using support vector machines and string kernels. BMC Bioinformatics 12: 446.
10. Knapp B, Dorffner G, Schreiner W, (2013) Early relaxation dynamics in the LC 13 T cell receptor in reaction to 172 altered peptide ligands: a molecular dynamics simulation study. PLoS ONE 8: e64464.
11. Stone JD, Chervin AS, Kranz DM, (2009) T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 126: 165–176.
12. Calis JJ, Maybeno M, Greenbaum JA, Weiskopf D, De Silva AD, et al. (2013) Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput Biol 9: e1003266.
13. Feltkamp MC, Vierboom MP, Kast WM, Melief CJ, (1994) Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol Immunol 31: 1391–1401.
14. Zoete V, Irving M, Ferber M, Cuendet MA, Michielin O, (2013) Structure-Based, Rational Design of T Cell Receptors. Front Immunol 4: 268.
15. Guy CS, Vignali DA, (2009) Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev 232: 7–21.
16. Krogsgaard M, Prado N, Adams EJ, He XL, Chow DC, et al. (2003) Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell 12: 1367–1378.
17. Frankild S, de Boer RJ, Lund O, Nielsen M, Kesmir C, (2008) Amino acid similarity accounts for T cell cross-reactivity and for “holes” in the T cell repertoire. PLoS ONE 3: e1831.
18. Choudhuri K, van der Merwe PA, (2007) Molecular mechanisms involved in T cell receptor triggering. Semin Immunol 19: 255–261.
19. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, et al. (2012) A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Immunol Rev 250: 61–81.
20. Narzi D, Becker CM, Fiorillo MT, Uchanska-Ziegler B, Ziegler A, et al. (2012) Dynamical characterization of two differentially disease associated MHC class I proteins in complex with viral and self-peptides. J Mol Biol 415: 429–442.
21. Knapp B, Omasits U, Bohle B, Maillere B, Ebner C, et al. (2009) 3-Layer-based analysis of peptide-MHC-interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Molecular Immunology 46: 1839–1844.
22. Bello M, Correa-Basurto J, (2013) Molecular dynamics simulations to provide insights into epitopes coupled to the soluble and membrane-bound MHC-II complexes. PLoS ONE 8: e72575.
23. Laimou D, Lazoura E, Troganis AN, Matsoukas MT, Deraos SN, et al. (2011) Conformational studies of immunodominant myelin basic protein 1–11 analogues using NMR and molecular modeling. J Comput Aided Mol Des 25: 1019–1032.
24. Wolfson MY, Nam K, Chakraborty AK, (2011) The effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study. J Phys Chem B 115: 8317–8327.
25. Kumar A, Cocco E, Atzori L, Marrosu MG, Pieroni E, (2013) Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study. PLoS ONE 8: e59711.
26. Omasits U, Knapp B, Neumann M, Steinhauser O, Stockinger H, et al. (2008) Analysis of Key Parameters for Molecular Dynamics of pMHC Molecules. Mol Simulat 34: 781–793.
27. Cuendet MA, Zoete V, Michielin O, (2011) How T cell receptors interact with peptide-MHCs: a multiple steered molecular dynamics study. Proteins 79: 3007–3024.
28. Knapp B, Omasits U, Schreiner W, Epstein MM, (2010) A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses. PLoS ONE 5: e11653.
29. Yaneva R, Springer S, Zacharias M, (2009) Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: A molecular dynamics simulation study. Biopolymers 91: 14–27.
30. Cuendet MA, Michielin O, (2008) Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex. Biophys J 95: 3575–3590.
31. Alvarez-Navarro C, Cragnolini JJ, Dos Santos HG, Barnea E, Admon A, et al. (2013) Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis. J Biol Chem 288: 25810–25825.
32. Knapp B, Fischer G, Van HD, Fae I, Maillere B, et al. (2012) Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background. BMC Immunol 13: 43.
33. Reboul CF, Meyer GR, Porebski BT, Borg NA, Buckle AM, (2012) Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex. PLoS Comput Biol 8: e1002404.
34. Wan S, Flower DR, Coveney PV, (2008) Toward an atomistic understanding of the immune synapse: Large-scale molecular dynamics simulation of a membrane-embedded TCR-pMHC-CD4 complex. Molecular Immunology 45: 1221–1230.
35. Painter CA, Cruz A, Lopez GE, Stern LJ, Zavala-Ruiz Z, (2008) Model for the peptide-free conformation of class II MHC proteins. PLoS ONE 3: e2403.
36. Rupp B, Gunther S, Makhmoor T, Schlundt A, Dickhaut K, et al. (2011) Characterization of structural features controlling the receptiveness of empty class II MHC molecules. PLoS ONE 6: e18662.
37. Stavrakoudis A, (2011) Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations. Cell Biochem Biophys 60: 283–295.
38. De Rosa MC, Giardina B, Bianchi C, Carelli AC, Pirolli D, et al. (2010) Modeling the ternary complex TCR-Vbeta/CollagenII(261–273)/HLA-DR4 associated with rheumatoid arthritis. PLoS ONE 5: e11550.
39. Ioannidis JP, (2005) Why most published research findings are false. PLoS Med 2: e124.
40. Ioannidis JP, (2007) Why most published research findings are false: author's reply to Goodman and Greenland. PLoS Med 4: e215.
41. Mullard A, (2011) Reliability of ‘new drug target’ claims called into question. Nat Rev Drug Discov 10: 643–644.
42. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, et al. (2003) A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18: 53–64.
43. Bergman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235–242.
44. Burrows SR, Silins SL, Cross SM, Peh CA, Rischmueller M, et al. (1997) Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. Eur J Immunol 27: 178–182.
45. Krivov GG, Shapovalov MV, Dunbrack RL, Jr (2009) Improved prediction of protein side-chain conformations with SCWRL4. Proteins 77: 778–795.
46. Knapp B, Giczi V, Ribarics R, Schreiner W, (2011) PeptX: Using Genetic Algorithms to optimize peptides for MHC binding. BMC Bioinformatics 12: 241.
47. Knapp B, Omasits U, Schreiner W, (2008) Side chain substitution benchmark for peptide/MHC interaction. Protein Sci 17: 977–982.
48. Knapp B, Omasits U, Frantal S, Schreiner W, (2009) A critical cross-validation of high throughput structural binding prediction methods for pMHC. J Comput Aided Mol Des 23: 301–307.
49. Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, et al. (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. BIOINFORMATICS 29: 845–854.
50. Oostenbrink C, Villa A, Mark AE, Van Gunsteren WF, (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25: 1656–1676.
51. Knapp B, Lederer N, Omasits U, Schreiner W, (2010) vmdICE: a plug-in for rapid evaluation of molecular dynamics simulations using VMD. J Comput Chem 31: 2868–2873.
52. Humphrey W, Dalke A, Schulten K, (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33–38.
53. Eisenhaber F, Lijnzaad P, Argos P, Sander C, Scharf M, (1995) The double cubic lattice method: Efficient approaches to numerical integration of surface area and volume and to dot surface contouring of molecular assemblies. J Comput Chem 16: 273–284.
54. Wang R, Lai L, Wang S, (2002) Further development and validation of empirical scoring functions for structure-based binding affinity prediction. Journal of Computer-Aided Molecular Design 16: 11–26.
55. Vreven T, Hwang H, Weng Z, (2011) Integrating atom-based and residue-based scoring functions for protein-protein docking. Protein Sci 20: 1576–1586.
56. Pierce B, Weng Z, (2007) ZRANK: reranking protein docking predictions with an optimized energy function. Proteins 67: 1078–1086.
57. Dunbar J, Fuchs A, Shi J, Deane CM, (2013) ABangle: characterising the VH-VL orientation in antibodies. Protein Eng Des Sel 26: 611–620.
58. Dien H, Deane CM, Knapp B, (2014) Gro2mat: A package to efficiently read Gromacs output in Matlab. J Comput Chem E-pub ahead of print. doi:10.1002/jcc.23650
59. Rammensee HG, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S, (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213–219.
60. Rudolph MG, Stanfield RL, Wilson IA, (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419–466.
61. Ferber M, Zoete V, Michielin O, (2012) T-cell receptors binding orientation over peptide/MHC class I is driven by long-range interactions. PLoS ONE 7: e51943.
62. Tung CW, Ho SY, (2007) POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties. Bioinformatics 23: 942–949.
63. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, et al. (2008) Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 36: W513–W518.
64. Flower DR, Phadwal K, Macdonald IK, Coveney PV, Davies MN, et al. (2010) T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges. Immunome Res 6(Suppl 2): S4.
65. Varani L, Bankovich AJ, Liu CW, Colf LA, Jones LL, et al. (2007) Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc Natl Acad Sci U S A 104: 13080–13085.
66. Feng D, Bond CJ, Ely LK, Maynard J, Garcia KC, (2007) Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction ‘codon’. Nat Immunol 8: 975–983.
67. de Almeida DE, Holoshitz J, (2011) MHC molecules in health and disease: At the cusp of a paradigm shift. Self Nonself 2: 43–48.
68. Madura F, Rizkallah PJ, Miles KM, Holland CJ, Bulek AM, et al. (2013) T-cell receptor specificity maintained by altered thermodynamics. J Biol Chem 288: 18766–18775.
69. Sadiq SK, Wright D, Watson SJ, Zasada SJ, Stoica I, et al. (2008) Automated molecular simulation based binding affinity calculator for ligand-bound HIV-1 proteases. J Chem Inf Model 48: 1909–1919.
70. Wan S, Coveney PV, Flower DR, (2005) Peptide recognition by the T cell receptor: comparison of binding free energies from thermodynamic integration, Poisson-Boltzmann and linear interaction energy approximations. Philos Trans A Math Phys Eng Sci 363: 2037–2053.
71. Colman PM, Laver WG, Varghese JN, Baker AT, Tulloch PA, et al. (1987) Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 326: 358–363.
72. Vargas-Madrazo E, Paz-Garcia E, (2003) An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues. J Mol Recognit 16: 113–120.